Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
06/2003
06/05/2003WO2003045322A2 Method for treating and preventing pancreatitis
06/05/2003WO2003045320A2 Somatostatin analog and uses thereof
06/05/2003WO2003045318A2 Manipulation of cytokine levels using cd83 gene products
06/05/2003WO2003045317A2 Therapeutic protein and treatments
06/05/2003WO2003045316A2 Polynucleotide therapy
06/05/2003WO2003045306A2 Phenoxy amine compounds and compositions for delivering active agents
06/05/2003WO2003045228A2 Methods for treating autoimmune disorders, and reagents related thereto
06/05/2003WO2003045225A2 Composition and method for treating the over-production of mucin in diseases such as otitis media using an inhibitor of muc5ac
06/05/2003WO2003045128A2 SYNTHETIC IMMUNOGENIC BUT NON-DEPOSIT-FORMING POLYPEPTIDES AND PEPTIDES HOMOLOGOUS TO AMYLOID β, PRION PROTEIN, AMYLIN, α-SYNUCLEIN, OR POLYGLUTAMINE REPEATS FOR INDUCTION OF AN IMMUNE RESPONSE THERETO
06/05/2003WO2003035667A3 Telomerase interference
06/05/2003WO2003029418A3 Proliferation and differentiation of stem cells using extracellular matrix and other molecules
06/05/2003WO2003024478A9 Treatment of central nervous system disorders by use of pdgf or vegf
06/05/2003WO2003010201A9 Blood group antigen fusion polypeptides and methods of use thereof
06/05/2003WO2003010197A3 Gmg-1 polynucleotides and polypeptides and uses thereof
06/05/2003WO2003004526A3 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or resistance to viruses and their use as medicines
06/05/2003WO2002102835A8 Novel antimicrobial compounds
06/05/2003WO2002102306A3 Methods and compositions for inhibiting, preventing, or reducing tumor cell growth in patients resistant to the antineoplastic effects of antiestrogen therapy
06/05/2003WO2002085843A3 Process for the preparation of 1,3-substituted indenes and aryl-fused azapolycyclic compounds
06/05/2003WO2002070704A3 Adipocyte complement related protein zacrp11
06/05/2003WO2002070002A3 Methods for regulation of immune responses to conditions involving mediator-induced pathology
06/05/2003WO2002064157A9 Localized myocardial injection method for treating ischemic myocardium
06/05/2003WO2002062841A3 Secreted proteins
06/05/2003WO2002060946A3 Methods and compositions relating to cardiac-specific nuclear regulatory factors
06/05/2003WO2002060932A3 A serpin in bifidobacteria
06/05/2003WO2002059350A3 Use of sialyltransferases for diagnosing and treating tumorous diseases
06/05/2003WO2002058712A3 Probiotic compounds derived from lactobacillus casei strain ke01
06/05/2003WO2002050301A3 Gene expression profiles associated with osteoblast differentiation
06/05/2003WO2002048351A3 A method for in vitro molecular evolution of protein function
06/05/2003WO2002048183A3 Compositions of peptide crystals
06/05/2003WO2002046230A3 G-protein coupled receptors
06/05/2003WO2002042330A3 Cystoskeleton-associated proteins
06/05/2003WO2002040673A3 Compositions and methods relating to lung specific genes and proteins
06/05/2003WO2002009718A3 Agents containing corticosteroids for reducing graft rejection reactions
06/05/2003WO2002007754A3 New use
06/05/2003US20030106084 Heat resistant antigen/cd24 fusion proteins; immunoglobulins; autoimmune disorders
06/05/2003US20030106073 Formylpeptide chemoattractant receptors(fpr-rs4); g-protein coupled receptors; antiepileptic agents
06/05/2003US20030105344 Method and apparatus for concentrating and stabilizing conjugated estrogens from mare urine
06/05/2003US20030105318 G-protein transmembrane domain; protein synthesis inhibitor; neurotransmitter
06/05/2003US20030105315 Cancer diagnosis; antitumor agents; antiproliferative agents; gene transfer agents
06/05/2003US20030105308 Polymerases; gene expression inhibition; gene therapy
06/05/2003US20030105302 Fibroblast cell growth factor; for diagnosis, detection and prevention of skin, cancer, brain, glandular, cell differentiation/ proliferative and placental disorders; antiproliferative agents, antitumor agents
06/05/2003US20030105300 Carbocyanine dyes/bioconjugates; optical tomography; fluorescence endoscopy; treating atherosclerotic plaques and blood clots; laser detection of metastasis
06/05/2003US20030105299 Carbocyanine dyes for tandem, photodiagnostic and therapeutic applications
06/05/2003US20030105297 Antibody; for diagnosis of bone, nervous system, blood, autoimmune and cancer disorders
06/05/2003US20030105295 Antagonists of interleukin-15
06/05/2003US20030105293 Human circulating cytokine cc-1
06/05/2003US20030105292 Continously induced g-protein coupled receptors; membrane binding assays
06/05/2003US20030105286 Comprises pseudo-isocytosine and pseudo-uracil for increasing binding affinity to DNA/RNA strands
06/05/2003US20030105285 Odorant receptors
06/05/2003US20030105284 Small and intermediate conductance, calcium-activated potassium channels and uses thereof
06/05/2003US20030105283 Antigenic protein originating in malassezia
06/05/2003US20030105281 Piscidides: antibiotic resistance
06/05/2003US20030105278 Melanin-concentrating hormone analogs
06/05/2003US20030105277 Tat transport proteins; antiproliferative agents; antitumor agents
06/05/2003US20030105165 Gap junctions and EDHF
06/05/2003US20030105138 Using carvedilol, or synergistic mixture thereof
06/05/2003US20030105126 Irrigation solution and method for inhibition of pain, inflammation, spasm and restenosis
06/05/2003US20030105114 Methods of treatment and kits comprising a growth hormone secretagogue
06/05/2003US20030105096 Serotonin transport inhibitors
06/05/2003US20030105092 Prevention of loss and restoration of bone mass by certain prostaglandin agonists
06/05/2003US20030105059 Regulation of human mast cell protease 6-like enzyme
06/05/2003US20030105058 CD44-like protein
06/05/2003US20030105057 Modulating the rate and/or amount of a cellular process selected from the group consisting of cell growth, cell detachment and cell migration, and cellular apoptosis by altering the RECEPTOR/PTK-STAT pathway of cell
06/05/2003US20030105054 For eliciting an immune response and enhancing current therapeutic modalities for the treatment of cancer; stimulates T cell proliferation
06/05/2003US20030105052 Oligoribonucleotide derivatives for specific inhibition of gene expression
06/05/2003US20030105051 Nucleic acid treatment of diseases or conditions related to levels of HER2
06/05/2003US20030105050 Disorders caused by overproduction of collagen fibres, for example, liver cirrhosis, kidney, liver and heart fibrosis, scleroderma, hypertrophic scars and keloids
06/05/2003US20030105049 For use in diagnosis and therapy
06/05/2003US20030105046 Therapy of amyotrophic lateral sclerosis and head trauma injury by inhibiting interleukin converting enzyme (ICE) by gene therapy
06/05/2003US20030105044 Antisense modulation of matrix metalloproteinase 1 expression
06/05/2003US20030105043 Introducing into the cell a ribozyme that inhibits metallothionein expression, wherein the ribozyme comprises a nucleotide sequence for inducing apoptosis in a human cancer cell
06/05/2003US20030105042 For therapy or prophylaxis of hypercholesterolemia and cancer
06/05/2003US20030105041 Antisense modulation of SHH expression
06/05/2003US20030105040 Antisense modulation of inhibitor-kappa B-R expression
06/05/2003US20030105038 Antisense modulation of CREB expression
06/05/2003US20030105037 Antisense modulation of inhibitor-kappa B kinase-gamma expression
06/05/2003US20030105036 Antisense Inhibition of vascular endothelial growth factor receptor-1 expression
06/05/2003US20030105035 Administering synthetic, oligonucleotide, antibody that binds to epidermal growth factor receptor or a cytotoxic agent selected from taxanes, platinum-derived agents, and topoisomeraseII-selective drugs for inhibiting proliferation
06/05/2003US20030105031 Administering therapeutically effective amount of one or more flavonoids and carrier for therapy of reactive and inflammatory dermatoses
06/05/2003US20030105027 Nutritional supplements and methods for prevention, reduction and treatment of radiation injury
06/05/2003US20030105026 For prophylaxis and therapy of infectious diseases such as viral hepatitis B and C, AIDS and herpes
06/05/2003US20030105025 Tri-and tetrapeptides having antiangiogenic activity
06/05/2003US20030105024 Methods and reagents for discovering and using mammalian melanocortin receptor agonists and antagonists to modulate feeding behavior in animals
06/05/2003US20030105022 Tetra-, penta-, hexa- and heptapeptides having antiangiogenic activity
06/05/2003US20030105021 Using peptide comprising a chain of 7 to 17 contiguous amino acids derived from region of human TNF- alpha from Ser100 to Glu116 or from region of mouse TNF- alpha from Ser99 to Glu115 for manufacture of a medicament for oedema
06/05/2003US20030105020 Use of a composition
06/05/2003US20030105018 Using vascular endothelial growth factor (VEGF) and homologues for the manufacture of a medicament to treat neuron disorders
06/05/2003US20030105017 Protecting free sulfhydryl groups of Troponin I under reducing conditions
06/05/2003US20030105016 Therapy and prophylaxis of lesion of the vaginal, cervical, or uterine epithelium of a mammal by administering intestinal trefoil peptide
06/05/2003US20030105015 Promoting growth of bone, ligament, or cartilage in a mammal by administering zvgef4 (endothelial growth factor) in delivery vehicle
06/05/2003US20030105014 Screening assay for the identification of inhibitors of macrophage migration inhibitory factor
06/05/2003US20030105013 For therapy of wounds, various cancers, and disorders of the vessels including atherosclerosis and cardiac hypertrophy
06/05/2003US20030105012 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
06/05/2003US20030105011 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
06/05/2003US20030105009 Polypeptides of covalently linked synthetic bioactive peptide analog(s) for treatment of cancer
06/05/2003US20030105008 Geminin and Orc3N inhibit replication of herpesviruses, papillomaviruses, and polyomaviruses
06/05/2003US20030105007 PDGF-betabeta and fibronectin combined in a solid wound dressing for the treatment of wounds
06/05/2003US20030105006 For therapy of bacterial infections
06/05/2003US20030105005 Administering to mammal an appetite-suppressing effective amount of growth hormone
06/05/2003US20030105004 Novel morphogenic protein compositions of matter
1 ... 1832 1833 1834 1835 1836 1837 1838 1839 1840 1841 1842 1843 1844 1845 1846 1847 1848 1849 1850 1851 1852 ... 3163